NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









OpenEvidence

OpenEvidence

Private
Miami, FloridaHealthcare & Life Scienceshttps://www.openevidence.com/

Last Round

Series D

Jan 21, 2026

Est. Valuation

$12B

Total Funding Raised

$735M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

OpenEvidence is a healthcare technology company that develops an AI-powered medical search engine and clinical decision support platform for healthcare professionals.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, NLP & Conversational AI, Healthcare Analytics, Drug Discovery, Clinical Trials

Business Model

B2B2C

Customer Profile

Data as a Service, Usage-Based SaaS

AI Layer

Application

Keywords

clinical decision supportmedical AIAI scribeclinical documentationevidence-based medicinecontinuing medical educationCMEmaintenance of certificationMOCdrug discoveryclinical trialvoice AIEHR integrationhealthcare SaaSmedical searchdoctor copilot

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

OpenEvidence Comparables

Compare OpenEvidence with similar companies based on industry and business-model similarity.

OpenEvidence comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
athenahealth
81%
Doximity
80%
Reed Business Information
77%

OpenEvidence Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series DJan 21, 2026
Series COct 20, 2025
Series BJul 15, 2025
Series AFeb 19, 2025

Secondary Market Activity

Bids, offers, and trades by month

Data table
OperationDatePriceSizeShare ClassStructure
BID

Key People

Founding team and executive leadership

James Phimister

Strategic Advisor To The CEO, National Health System Partnerships

Executive Team

Laurent Schockmel

Strategic Advisor To The CEO

Executive Team

OpenEvidence Investors

Notable investors and investment history

OpenEvidence investors
InvestorRounds
DST GlobalSeries D
BlackstoneSeries C
GVSeries C, Series B
ConvictionSeries B
Craft VenturesSeries C
Thrive CapitalSeries C, Series B, Series D
Sequoia CapitalSeries C, Series B, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 1, 2026

    Open job postings surged to 11 roles, 2.1x the trailing average.

  • Jun 8, 2026

    Open job postings increased from 0 to 11 roles.

OpenEvidence Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

OpenEvidence Filings

SEC and related filings with document metadata.

Appears On

Curated lists and screens where this company is featured.

Frequently Asked Questions

Common questions about OpenEvidence's valuation, stock price, and market status.

Firmographic Details

HeadquartersMiami, Florida
Employee Range123
Year Founded2022
Last FundingJan 21, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.